Pasadena, California-based Alexandria Real Estate Equities, Inc. (ARE) is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. Valued at $12.3 billion by market cap, the company acquires, manages, expands, and develops office and laboratory space properties. It leases its properties to pharmaceutical, biotechnology, diagnostic and personal care products companies, research institutions, and related government agencies.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and ARE perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the REIT - office industry. ARE has pioneered life science real estate, establishing itself as a market leader, by focusing on innovation-driven sectors like life science, agtech, and technology. Strategic investments in Class A properties and collaborative environments create a dynamic ecosystem, boosting competitiveness. With a presence in key markets like Greater Boston, San Francisco Bay Area, and New York City, ARE benefits from geographical diversity, mitigating risks and unlocking revenue opportunities.
